ENHANCED HA
Live / Registered — Registered (as of 11 Aug 2026)
What this means for you
Registered since 11 Aug 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 11 Aug 2032: the §8 declaration of use).
Record
- Serial number
- 99226554
- Registration number
- 8396693
- Mark type
- Word mark
- Filed
- 10 Jun 2025
- Registered
- 11 Aug 2026
- Next maintenance filing
- §8 declaration of use, due by 11 Aug 2032 (grace period to 11 Feb 2033)
- Attorney of record
- Lindsay Heather Kaplan
Goods and services
- Class 005 — Pharmaceuticals: Solutions for medical and clinical use in storing and treating cells, blood and blood components; Reagents for blood grouping for medical purposes; Hyaluronic acid for pharmaceutical purposes; Pharmaceutical preparations for wounds; Pharmaceutical preparations for skin care; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for use in regenerative medicine, aesthetic medicine, and dermatology; Pharmaceutical preparations for cellular therapy for the treatment of damaged skin or tissue; Chemical preparations for pharmaceutical or medical purposes, namely, for the preparation of autologous biological products; Biologics in the nature of cells for medical use; Biologics in the nature of pharmaceutical preparations for the treatment of damaged skin or tissue; Biologics in the nature of cells for the treatment of damaged skin or tissue; Biological tissue cultures for medical use; Biological tissue cultures for medical purposes; Reagents for medical use; Biological reagents for medical purposes; Anticoagulants; all of the foregoing containing hyaluronic acid, or used in association with hyaluronic acid, or used before, during or after a hyaluronic acid procedure.
- Class 010 — Medical apparatus: Medical devices, namely, tubing and bag assembly set and other similar or related devices, which process and treat human platelets with clinical medical reagents for the purpose of enabling the refrigerated storage of human platelets for blood groups for use in blood transfusions; Blood drawing apparatus; Blood collection needles; Filters for blood and blood components for medical purposes; Apparatus for taking blood; Blood containers for medical purposes; Blood component separation apparatus for medical purposes; Blood collection bags for veterinary purposes; Blood storage bags for medical purposes; Blood tubing sets for medical purposes; Blood collection bags for medical purposes; Blood collection kit comprised of blood collection bag, holder for medical sample tubes and vials, and medical sample tubes and vials; Medical apparatus for introducing pharmaceutical preparations into the human body; Medical syringes; Hypodermic syringes; all of the foregoing containing hyaluronic acid, or used in association with hyaluronic acid, or used before, during or after a hyaluronic acid procedure.
Owner
- RegenSkin LLC, Jersey City, NJ, US
- RegenSkin LLC, Jersey City, NJ, US
Prosecution history
- 11 Aug 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 11 Aug 2026 — REGISTERED-SUPPLEMENTAL REGISTER
- 14 Jul 2026 — APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
- 22 Jun 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 22 Jun 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 22 Jun 2026 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 15 Jun 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 15 Jun 2026 — FINAL REFUSAL E-MAILED
- 15 Jun 2026 — FINAL REFUSAL WRITTEN
- 22 May 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 22 May 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 22 May 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 23 Feb 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 Feb 2026 — NON-FINAL ACTION E-MAILED
- 23 Feb 2026 — NON-FINAL ACTION WRITTEN